TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NOVO NORDISK INC. · A global healthcare company focused on diabetes and other serious chronic diseases

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Health Issues

IRA, medication affordability and access, general diabetes prevention, obesity, impacts of drug shortages, drug supply chain

Medicare/Medicaid

Treat and Reduce Obesity Act, obesity treatment

Budget/Appropriations

Federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.